LATEST UPDATES » Vol 23, No 07, July 2019 – Traditional Chinese medicine in modern healthcare — Integrating both worlds       » China approves norovirus vaccine for clinical trial       » AI offers breakthrough in cancer diagnosis       » Digital mental health strategy in China       » A wearable that's not to be laughed at       » Junk food could be responsible for the food allergy epidemic      
New bid to stamp out bowel cancer
Flinders researchers awarded A$553,196 for blood test to detect bowel cancer

Flinders cancer experts have been awarded a grant of A$553,196 to improve the survival and recovery of colorectal cancer patients via a simple blood test.

Bowel cancer is one of the most common cancers in Australia. Each day, 46 people are diagnosed with bowel cancer in Australia while approximately 11 people die from the disease.

Cancer Australia says less than 50 per cent of cases of bowel cancer are diagnosed at an early stage when it can be most successfully treated. In Australia, 24 percent of bowel cancers were diagnosed at stage three and 18 percent at stage four.

Chief investigator Dr Erin Symonds, principal medical scientist and team leader of the Bowel Health Service at Flinders Medical Centre said, “Despite surgery, approximately one-quarter to one-third of patients will have the cancer return within three years”.

Together with her team, they have developed and evaluated a blood test that can detect bowel cancer and if it can also be used to determine which patients are at higher risk for cancer recurrence.

If detected early, up to 90 percent of bowel cancer cases can be successfully treated.

"The blood test will hopefully be used to determine how best to treat a patient after their bowel cancer is surgically removed.

“This would allow specialists to focus therapies, especially chemotherapy, on those who are likely to most benefit - and avoid it in those who do not need it," she said.

The Cancer Australia research project, entitled ‘Personalising treatment and surveillance for colorectal cancer: prognostication with the circulating tumour-derived methylated DNA markers BCAT1 and IKZF1,’ builds on research in the field at Flinders.

The research will use the pioneering 'Colvera' blood test in patients who have already had bowel cancer - whatever their age.

A recent analysis by the Australian Institute of Health and Welfare shows that bowel cancer screening is effective in reducing bowel cancer death rates, yet participation remains low at 41 per cent.

The Australian Government is aiming to send a kit every two years to people aged 50-74 by 2020.

Click here for the complete issue.

news Which country has the worst sleepers
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
Asia Pacific Biotech News

APBN Editorial Calendar 2019
Taiwan Medical tourism
Marijuana as medicine — Legal marijuana will open up scientific research
Driven by curiosity
Career developments for researchers
What's cracking — Antibodies in ostrich eggs
Clinical trials — What's in a name?
Traditional Chinese medicine in modern healthcare — Integrating both worlds
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy